Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Sparing Techniques in Gender Affirming Surgery
NCT04979338Phase 3Recruiting
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Nov 2021
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine in postoperative pain, sponsored by Cedars-Sinai Medical Center. Started Nov 2021; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04979338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04979338.